Information  X 
Enter a valid email address

Astrazeneca PLC OrdShs USD0.25 (AZN)

Related News

06-Apr-2020 08:10 AM

Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC

Liberum Capital today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8870p (from 8810p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
31-Mar-2020 11:30 AM

Broker Forecast - Oddo issues a broker note on AstraZeneca PLC

Oddo today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 7600p (from 8000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
17-Mar-2020 08:30 AM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 8000p (from 8500p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
03-Mar-2020 12:10 PM

Broker Forecast - UBS issues a broker note on AstraZeneca PLC

UBS today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 6000p (from 5800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
25-Feb-2020 08:30 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 8300p (from 8400p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
18-Feb-2020 10:10 AM

Broker Forecast - Kepler Cheuvreux issues a broker note on AstraZeneca PLC

Kepler Cheuvreux today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 7700p (from 8000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
14-Feb-2020 07:27 AM

AstraZeneca profit falls 22% as selling costs offset rising revenue

Pharmaceutical company AstraZeneca posted a 22% fall in annual profit after rising revenue was offset by an increase in selling and other administrative costs. Pre-tax profit for the year through December fell to $1.55bn, down from $1.99bn on-year. Reve
22-Jan-2020 08:00 AM

Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC

Liberum Capital today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8810p (from 8300p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
16-Jan-2020 09:20 AM

Broker Forecast - Credit Suisse issues a broker note on AstraZeneca PLC

Credit Suisse today reaffirms its outperform investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8500p (from 8200p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
16-Jan-2020 08:20 AM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8500p (from 8300p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
06-Jan-2020 12:10 PM

Broker Forecast - Morgan Stanley issues a broker note on AstraZeneca PLC

Morgan Stanley today reaffirms its equal weight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8100p (from 7400p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
06-Jan-2020 10:20 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on AstraZeneca PLC

JP Morgan Cazenove today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8500p (from 7900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
17-Dec-2019 01:30 PM

Broker Forecast - Credit Suisse issues a broker note on AstraZeneca PLC

Credit Suisse today reaffirms its outperform investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8200p (from 7300p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
12-Dec-2019 08:30 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8400p (from 8300p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
27-Nov-2019 08:50 AM

Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC

Liberum Capital today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8300p (from 8250p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
25-Nov-2019 10:20 AM

Broker Forecast - Bryan Garnier issues a broker note on AstraZeneca PLC

Bryan Garnier today upgrades its investment rating on AstraZeneca PLC (LON:AZN) to buy (from neutral) and raised its price target to 7950p (from 7700p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
22-Nov-2019 11:40 AM

Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8300p (from 8200p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
30-Oct-2019 08:00 AM

Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC

Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8300p (from 7800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
29-Oct-2019 10:50 AM

Broker Forecast - Kepler Cheuvreux issues a broker note on AstraZeneca PLC

Kepler Cheuvreux today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8000p (from 7700p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
29-Oct-2019 09:40 AM

Broker Forecast - UBS issues a broker note on AstraZeneca PLC

UBS today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 5800p (from 5700p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
25-Oct-2019 08:40 AM

Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC

Liberum Capital today upgrades its investment rating on AstraZeneca PLC (LON:AZN) to buy (from hold). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
24-Oct-2019 07:45 AM

AstraZeneca upgrades sales guidance following 16% growth in Q3

AstraZeneca upgraded its guidance on product sales following a 16% rise in the third quarter of the year, led by growth in its portfolio of cancer drugs. Product sales at constant currency were now expected to increase by a low to mid-teens percentage;
15-Oct-2019 09:20 AM

Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC

Jefferies International today reaffirms its hold investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 6700p (from 6550p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
23-Sep-2019 07:19 AM

AstraZeneca sees Qtrilemt recommended for approval in EU

AstraZeneca has announced that Qtrilment has been recommended for marketing authorisation in the EU by the Committe for Medicinal Products for Human Use (CHMP). The CHMP recommended this for Qtrilmet to improve glycaemic control when metformin with or wi
18-Sep-2019 07:16 AM

AstraZeneca amends collaboration with Ironwood

AstraZeneca has amended its collaboration agreement with Ironwood Pharmaceuticals in China mainland, China Hong Kong, and China Macau for Linzess. This new agreement gives AstraZeneca full responsibility for developing, manufacturing, and commercialising
 
Headlines
Top categories

06-Apr-2020 04:50 PM

Broker Forecast - HSBC issues a broker note on McCarthy Stone Plc

HSBC today reaffirms its buy investment rating on McCarthy Stone Plc (LON:MCS) and cut its price target to 100p (from 190p). Story provided by StockM ...

Company finder
Forthcoming announcements

a d v e r t i s e m e n t